Letters
Advance Access publication 17 April 2009 Mutations in the RARE and MARE regulatory sequences of HNF1B are not a frequent cause of kidney/urinary tract malformation Sir, Mutations in several genes have been identified in congenital abnormalities of kidneys and urinary tract (CAKUT): heterozygous mutations in HNF1β account for 8%, while other genes (PAX2, EYA1, SALL1, SIX1) have been identified as causing isolated renal hypo/dysplasia to a lesser extent in humans [1] .
Despite extensive HNF1β molecular analysis, including direct sequencing of the minimal promoter and of the nine exons associated with screening for exonic rearrangement, HNF1β genetic testing failed to identify mutations in a majority of patients with CAKUT, even in individuals with very evocative renal phenotype [2, 3] . Recently, specifically conserved cis-acting RARE (retinoic acid responsive element) and T-MARE (MafB responsive element) regulatory sequences have been identified [4] . RA signalling cascade and MafB bind RARE and T-MARE regulatory DNA sequences, respectively, and promote the expression of Hnf1β in both the caudal hindbrain (r4/r5 boundary) and pancreas. These sequences are both located in intron 4 of HNF1β and are not actually studied for the purpose of diagnosis. Finally, the roles of RA and MAFB in kidney development suggest that the RA-MAFB-HNF1β pathway may also be functional in human kidney.
In this study, we hypothesized that mutations in the highly conserved (see Figure 1 ) RARE and T-MARE regulatory sequences could disturb the early embryologic process of intermediate mesoderm, from which kidneys and urinary tract both derived, and consequently lead to renal phenotype mimicking HNF1β-related nephropathy.
Among the 63 individuals we tested for HNF1β, a mutation was identified in 12 (19%). We therefore performed molecular analysis of these regulatory sequences in the 51 remaining patients with isolated or syndromic CAKUT of unknown origin for whom previous molecular analysis of HNF1β (QMPSF and direct sequencing) had failed to identify any causative mutation. All patients gave informed consent according to French law. Renal and extrarenal features of the 51 tested patients [31 males, 20 females, median age 9 years (0-53)] are summarized in Tables 1 and 2 , respectively. RARE and T-MARE regulatory sequences were amplified by PCR using a set of primers deduced from the genomic sequence (forward: TC CCCAGAACCCTCTTCCTA, reverse: TGGTTCAAAGC CCCAACTTA), corresponding to amplification of a 344 bp fragment (G1266-17138 to G1266-16794). Among the 51 tested patients, no sequence variation of the RARE CAKUT: congenital abnormalities of kidneys and urinary tract, VUR: vesico-ureteric reflux, UPJO: uretero-pyelic junction obstruction. and T-MARE regulatory sequences of HNF1β was evidenced.
In conclusion, although mutations in RARE and T-MARE regulatory sequences of HNF1β may nevertheless be implicated in some renal congenital disorders, we show here that mutations in these sequences are not a frequent cause of CAKUT. More experiments are required to assess the role of the RA-MAFB-HNF1β pathway in kidney development. Moreover, the molecular basis of these renal malformations is still poorly understood, and further works remain to be done to identify new CAKUT genes. Delineation of transcriptional networks involved in early human metanephros development may be a way to identify these new genes.
Conflict of interest statement. None declared. Sir, Recent, New techniques based on conductivity measurement enable physicians to evaluate the adequacy of Hospal-Gambro, Mirandola, Italy) is a parameter calculated from the dialysate conductivity at the dialyser inlet and outlet. Every half hour, the inlet dialysate conductivity increases by 1 ms/cm during 5 min, while the outlet dialysate conductivity-cell measures the effect of this increase. The calculated ion transfer across the membrane (largely sodium) is almost equivalent to urea transfer and therefore ionic dialysance reflects the urea clearance. This method has been shown to have a good correlation with Kt/V measured by the mathematical urea equations in several studies [1] [2] [3] [4] . However, some investigators suggest that during the conductivity pulse of 5 min, significant amounts of sodium may be transferred into the patient [5] . In our centre, we studied that effect. Diascan R also measures ionic mass balance (IMB) and plasma conductivity (PC) that are likely to represent sodium balance and plasma sodium, respectively (plasma sodium in mmol/l ≈ plasma conductivity in ms/ cm × 10). This is performed by constant measurements of the conductivity in the dialysate inlet and outlet, according to the formulas
where Qd in and Qd out are dialysate flow at, respectively, inlet and outlet, Cd in and Cd out are dialysate conductivity at, respectively, inlet and outlet and D is ionic dialysance, and IMB = (Qd in × Cd in − Qd out × Cd out ) × 10 × time(min).
A positive IMB means sodium removal from the patient. A negative IMB means sodium transport to the patient.
In patients with zero inter-diaytic weight gain, IMB was measured in 200 isovolaemic haemodialysis sessions by Diascan R , 137 sessions were performed with four to eight conductivity pulses. A total of 63 sessions was performed with only one conductivity pulse.
The results showed a highly significant correlation between pre-dialytic plasma conductivity and IMB (Spearman rank r s = 0.902, P < 0.005), in agreement with previous studies [6] . There was no correlation between IMB and the number of conductivity pulses (Spearman rank r s = 0.02, P = 0.328) (Figure 1 ).
